PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY

Current recommendations for monitoring patients with chronic myeloid leukemia (CML) provide recommendations for response assessment and treatment only at 3, 6, 12, and 18 months. These recommendations are based on clinical trial outcomes computed from treatment start. Conditional survival estimates...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Quintás-Cardama, Alfonso, Choi, Sangbum, Kantarjian, Hagop, Jabbour, Elias, Huang, Xuelin, Cortes, Jorge
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099320/
https://ncbi.nlm.nih.gov/pubmed/24594142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.01.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak